questionsmedicales.fr
Maladies du système immunitaire
Hypersensibilité
Hypersensibilité immédiate
Hypersensibilité respiratoire
Aspergillose bronchopulmonaire allergique
Aspergillose bronchopulmonaire allergique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Aspergillose
Tests d'allergie
Culture microbiologique
Aspergillose
Antécédents médicaux
Asthme
Symptômes
5
Variabilité des symptômes
Aspergillose
Allergies
Infection fongique
Prévention
5
Traitements préventifs
Risque élevé
Traitements
5
Corticostéroïdes
Antifongiques
Corticostéroïdes
Inflammation
Antifongiques
Infection fongique
Bronchodilatateurs
Essoufflement
Immunothérapie
Traitements alternatifs
Complications
5
Complications
Infections pulmonaires
Bronchiectasies
Inflammation
Insuffisance respiratoire
Cas graves
Gestion des symptômes
Prévention
Facteurs de risque
5
Facteurs de risque
Asthme
Fibrose kystique
Aspergillose
Personnes âgées
Infections fongiques
Exposition professionnelle
Aspergillose
Antécédents d'allergies
Vulnérabilité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Aspergillose bronchopulmonaire allergique : Questions médicales les plus fréquentes",
"headline": "Aspergillose bronchopulmonaire allergique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Aspergillose bronchopulmonaire allergique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-21",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Aspergillose bronchopulmonaire allergique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hypersensibilité respiratoire",
"url": "https://questionsmedicales.fr/mesh/D012130",
"about": {
"@type": "MedicalCondition",
"name": "Hypersensibilité respiratoire",
"code": {
"@type": "MedicalCode",
"code": "D012130",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.480.680"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Aspergillose bronchopulmonaire allergique",
"alternateName": "Aspergillosis, Allergic Bronchopulmonary",
"code": {
"@type": "MedicalCode",
"code": "D001229",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ritesh Agarwal",
"url": "https://questionsmedicales.fr/author/Ritesh%20Agarwal",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India. Electronic address: agarwal.ritesh@outlook.in."
}
},
{
"@type": "Person",
"name": "Valliappan Muthu",
"url": "https://questionsmedicales.fr/author/Valliappan%20Muthu",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India."
}
},
{
"@type": "Person",
"name": "Sahajal Dhooria",
"url": "https://questionsmedicales.fr/author/Sahajal%20Dhooria",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India."
}
},
{
"@type": "Person",
"name": "Arunaloke Chakrabarti",
"url": "https://questionsmedicales.fr/author/Arunaloke%20Chakrabarti",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India."
}
},
{
"@type": "Person",
"name": "Inderpaul Singh Sehgal",
"url": "https://questionsmedicales.fr/author/Inderpaul%20Singh%20Sehgal",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Youths' perceptions and behaviors on COVID-19 testing.",
"datePublished": "2023-08-11",
"url": "https://questionsmedicales.fr/article/37566576",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0290007"
}
},
{
"@type": "ScholarlyArticle",
"name": "A longitudinal study of COVID-19 disclosure stigma and COVID-19 testing hesitancy in the United States.",
"datePublished": "2022-08-26",
"url": "https://questionsmedicales.fr/article/36182746",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.puhe.2022.08.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Geographic disparities in COVID-19 testing and outcomes in Florida.",
"datePublished": "2023-01-11",
"url": "https://questionsmedicales.fr/article/36631768",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-022-14450-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Emerging clinically tested detection methods for COVID-19.",
"datePublished": "2022-06-15",
"url": "https://questionsmedicales.fr/article/35490403",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/febs.16469"
}
},
{
"@type": "ScholarlyArticle",
"name": "The importance of quarantine: modelling the COVID-19 testing process.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37097481",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00285-023-01916-6"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hypersensibilité",
"item": "https://questionsmedicales.fr/mesh/D006967"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité immédiate",
"item": "https://questionsmedicales.fr/mesh/D006969"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hypersensibilité respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012130"
},
{
"@type": "ListItem",
"position": 6,
"name": "Aspergillose bronchopulmonaire allergique",
"item": "https://questionsmedicales.fr/mesh/D001229"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Aspergillose bronchopulmonaire allergique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Aspergillose bronchopulmonaire allergique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Aspergillose bronchopulmonaire allergique",
"description": "Comment diagnostiquer l'aspergillose bronchopulmonaire allergique ?\nQuels tests sont utilisés pour le diagnostic ?\nLes symptômes sont-ils suffisants pour le diagnostic ?\nQuel rôle joue la culture de mucus dans le diagnostic ?\nLes antécédents médicaux sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=COVID-19+Testing#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Aspergillose bronchopulmonaire allergique",
"description": "Quels sont les symptômes courants de cette maladie ?\nLa fièvre est-elle un symptôme fréquent ?\nY a-t-il des symptômes spécifiques chez les asthmatiques ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?\nPeut-on avoir des symptômes sans infection active ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=COVID-19+Testing#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Aspergillose bronchopulmonaire allergique",
"description": "Comment prévenir l'aspergillose bronchopulmonaire allergique ?\nLes personnes allergiques doivent-elles prendre des précautions ?\nLe port de masques est-il recommandé ?\nL'humidité intérieure joue-t-elle un rôle ?\nLes traitements préventifs sont-ils disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=COVID-19+Testing#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Aspergillose bronchopulmonaire allergique",
"description": "Quels traitements sont disponibles pour cette condition ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand utilise-t-on des antifongiques ?\nLes bronchodilatateurs sont-ils nécessaires ?\nY a-t-il des traitements alternatifs ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=COVID-19+Testing#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Aspergillose bronchopulmonaire allergique",
"description": "Quelles complications peuvent survenir ?\nLes bronchiectasies sont-elles une complication fréquente ?\nL'insuffisance respiratoire est-elle possible ?\nLes complications peuvent-elles être évitées ?\nY a-t-il un risque de mortalité ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=COVID-19+Testing#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Aspergillose bronchopulmonaire allergique",
"description": "Quels sont les principaux facteurs de risque ?\nLa fibrose kystique augmente-t-elle le risque ?\nLes personnes âgées sont-elles plus à risque ?\nL'exposition professionnelle joue-t-elle un rôle ?\nLes antécédents d'allergies augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001229?mesh_terms=COVID-19+Testing#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'aspergillose bronchopulmonaire allergique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical, les tests d'allergie et les examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent des tests cutanés, des dosages d'IgE spécifiques et des radiographies thoraciques."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils suffisants pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes doivent être corroborés par des tests spécifiques pour un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la culture de mucus dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture de mucus peut aider à identifier la présence d'Aspergillus dans les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux sont-ils importants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents d'allergies ou d'asthme sont cruciaux pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de cette maladie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, essoufflement, fièvre et production de mucus coloré."
}
},
{
"@type": "Question",
"name": "La fièvre est-elle un symptôme fréquent ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre peut survenir, surtout lors d'une exacerbation des symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les asthmatiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les asthmatiques peuvent éprouver une aggravation de l'asthme et des crises plus fréquentes."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans infection active ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes allergiques peuvent survenir sans infection fongique active."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'aspergillose bronchopulmonaire allergique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition aux spores d'Aspergillus et maintenir un environnement propre."
}
},
{
"@type": "Question",
"name": "Les personnes allergiques doivent-elles prendre des précautions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent éviter les zones à forte concentration de spores, comme les chantiers de construction."
}
},
{
"@type": "Question",
"name": "Le port de masques est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter un masque peut réduire l'exposition aux spores dans des environnements à risque."
}
},
{
"@type": "Question",
"name": "L'humidité intérieure joue-t-elle un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un faible taux d'humidité peut aider à réduire la prolifération des spores."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs sont-ils disponibles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements préventifs peuvent être envisagés pour les patients à risque élevé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour cette condition ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des corticostéroïdes, des antifongiques et des bronchodilatateurs."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent l'inflammation et améliorent les symptômes respiratoires."
}
},
{
"@type": "Question",
"name": "Quand utilise-t-on des antifongiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antifongiques sont utilisés en cas d'infection fongique confirmée ou sévère."
}
},
{
"@type": "Question",
"name": "Les bronchodilatateurs sont-ils nécessaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à soulager l'essoufflement et à améliorer la respiration."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs comme l'immunothérapie peuvent être envisagés dans certains cas."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections pulmonaires, des bronchiectasies et une insuffisance respiratoire."
}
},
{
"@type": "Question",
"name": "Les bronchiectasies sont-elles une complication fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent se développer en raison de l'inflammation chronique des voies respiratoires."
}
},
{
"@type": "Question",
"name": "L'insuffisance respiratoire est-elle possible ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une insuffisance respiratoire peut survenir dans les cas graves ou non traités."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion précoce et appropriée des symptômes peut aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de mortalité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans les cas graves, le risque de mortalité peut augmenter, surtout chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'asthme, la fibrose kystique et l'immunodépression."
}
},
{
"@type": "Question",
"name": "La fibrose kystique augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients atteints de fibrose kystique sont plus susceptibles de développer cette maladie."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé peut augmenter la susceptibilité aux infections fongiques."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs exposés à des spores d'Aspergillus, comme les agriculteurs, sont à risque."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents d'allergies respiratoires sont plus vulnérables."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 16/04/2025
Contenu vérifié selon les dernières recommandations médicales
14 publications dans cette catégorie
Affiliations :
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India. Electronic address: agarwal.ritesh@outlook.in.
11 publications dans cette catégorie
Affiliations :
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India.
11 publications dans cette catégorie
Affiliations :
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India.
8 publications dans cette catégorie
Affiliations :
Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
8 publications dans cette catégorie
Affiliations :
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
5 publications dans cette catégorie
Affiliations :
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India.
Publications dans "Aspergillose bronchopulmonaire allergique" :
5 publications dans cette catégorie
Affiliations :
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India.
Publications dans "Aspergillose bronchopulmonaire allergique" :
5 publications dans cette catégorie
Affiliations :
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Publications dans "Aspergillose bronchopulmonaire allergique" :
5 publications dans cette catégorie
Affiliations :
Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Publications dans "Aspergillose bronchopulmonaire allergique" :
5 publications dans cette catégorie
Affiliations :
Professor, Department of Pulmonary Medicine.
Publications dans "Aspergillose bronchopulmonaire allergique" :
3 publications dans cette catégorie
Affiliations :
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India.
Publications dans "Aspergillose bronchopulmonaire allergique" :
3 publications dans cette catégorie
Affiliations :
Division of Respiratory Medicine, Iwata City Hospital, 512-3 Ookubo, Iwata, Shizuoka, 438-8550, Japan.
Publications dans "Aspergillose bronchopulmonaire allergique" :
3 publications dans cette catégorie
Affiliations :
Division of Respiratory Medicine, Iwata City Hospital, 512-3 Ookubo, Iwata, Shizuoka, 438-8550, Japan.
Publications dans "Aspergillose bronchopulmonaire allergique" :
3 publications dans cette catégorie
Affiliations :
Division of Respiratory Medicine, Iwata City Hospital, 512-3 Ookubo, Iwata, Shizuoka, 438-8550, Japan.
Publications dans "Aspergillose bronchopulmonaire allergique" :
3 publications dans cette catégorie
Affiliations :
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handa-yama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Publications dans "Aspergillose bronchopulmonaire allergique" :
3 publications dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1, Sakamoto, Nagasaki 852-8501, Japan.
Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1, Sakamoto, Nagasaki 852-8501, Japan.
Publications dans "Aspergillose bronchopulmonaire allergique" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Disease, Faculty of Medicine, Imperial College, London, UK.
Publications dans "Aspergillose bronchopulmonaire allergique" :
2 publications dans cette catégorie
Affiliations :
Aix-Marseille Univ, MEPHI, Marseille, France; IHU Méditerranée Infection, Marseille, France; Desbrest Institute of Epidemiology and Public Health IDESP, Univ Montpellier, INSERM UA 11, Montpellier, France.
Publications dans "Aspergillose bronchopulmonaire allergique" :
2 publications dans cette catégorie
Affiliations :
Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University Daisan Hospital, Komae, Tokyo, Japan ntakasaka@jikei.ac.jp.
Publications dans "Aspergillose bronchopulmonaire allergique" :
2 publications dans cette catégorie
Affiliations :
Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University Daisan Hospital, Komae, Tokyo, Japan.
Publications dans "Aspergillose bronchopulmonaire allergique" :
Social gatherings are frequent sources of COVID-19 infections, especially among youth. However, little is known about youth testing behaviors before and after gatherings. Our aim was to assess behavio...
Five open-ended questions were texted to participants aged 14-24 throughout the United States via MyVoice. Using a content analysis approach, two investigators reviewed responses by question, develope...
Of 1204 participants, 989 responded to at least one question (RR = 94.1%). The mean age was 20.2 years (SD: 2.4 years). Most participants (80.7%) reported testing for COVID-19 at least once. Most (70....
Youth in our nationwide sample are likely to test for COVID-19 after an event, though less likely if they are vaccinated. Their desire to test is primarily driven by symptoms, exposures, and requireme...
This study examines the relationship between COVID-19 disclosure stigma and COVID-19 testing hesitancy and assesses their changes between November 2020 and 2021....
This was a longitudinal cohort....
A total of 355 participants completed four study waves between November 2020 and November 2021. Factor analyses and Cronbach's alpha assessed the factor structure and internal consistency of the COVID...
COVID-19 disclosure stigma declined significantly between the last study waves (P = 0.030). The greatest disclosure concern was reporting a positive test to close contacts (range: 19%-21%) followed by...
Study findings suggest that many people anticipate feeling stigmatized when disclosing positive test results, especially to close contacts. A substantial percentage of study participants reported hesi...
Understanding geographic disparities in Coronavirus Disease 2019 (COVID-19) testing and outcomes at the local level during the early stages of the pandemic can guide policies, inform allocation of con...
Visual examination of spatial patterns showed high estimates of all COVID-19 metrics for Southern Florida. Similar to the spatial patterns, high-risk clusters for testing and positivity rates and all ...
Substantial disparities in the spatial distribution of COVID-19 outcomes and testing and positivity rates exist in Florida, with Southern Florida counties generally having higher testing and positivit...
At the time of writing, there were 486 761 597 global cases of COVID-19 with 6 142 735 confirmed deaths (World Health Organization, 4 April 2022). According to the scarcity of information about estima...
We incorporate the disease state and testing state into the formulation of a COVID-19 epidemic model. For this model, the basic reproduction number is identified and its dependence on model parameters...
The SARS-CoV-2 pandemic, and the subsequent limitations on standard diagnostics, has vastly expanded the user base of Reverse Transcription Loop-mediated isothermal Amplification (RT-LAMP) in fundamen...
This review discusses the role of RT-LAMP within the context of other technologies like RT-qPCR and rapid antigen tests, progress in sample preparation strategies to enable simplified workflow for RT-...
RT-LAMP occupies a middle ground between RT-qPCR and rapid antigen tests. The simplicity approaches that of rapid antigen tests, making it suitable for point-of-care use, but the sensitivity nears tha...
The last three years have been spent combating COVID-19, and governments have been seeking optimal solutions to minimize the negative impacts on societies. Although two types of testing have been perf...
Polymerase chain reaction is a well-known method for testing COVID-19 infection, however, refugee populations often face difficulties in accessing testing. Several structural and cultural challenges h...
To explore barriers to accessing COVID-19 testing by Syrian refugees in Lebanon....
This qualitative study conducted 10 focus group discussions among Syrian refugees and 21 individual semistructured interviews with healthcare workers. Ethical approval was obtained from the Institutio...
Syrian refugees in Lebanon did not consider COVID-19 testing to be important. Despite the availability of free testing services, psychological, cultural, environmental, and financial barriers hindered...
Findings from this study add to existing literature regarding the social and cultural barriers to COVID-19 testing among Syrian refugees and should be considered when tailoring health promotion campai...
In Munich, the first German case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected on 27 January 2020 at the Division of Infectious Diseases and Tropical Medicine of the Uni...
Our retrospective observational study was conducted to determine the effects of public health measures on the utilization of a testing facility and positivity rates from the first operational COVID-19...
In total 9861 tests were conducted on 6989 clients. The clients were mostly young (median age: 34), female (60.58%), and asymptomatic (67.89%). Among those who tested positive for SARS-CoV-2, 67.72% w...
We could show that implementation or changes in public health measures have a strong effect on the utilization of testing facilities by the general public, which independently of the true epidemiologi...
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spreads rapidly, causing outbreaks that grow exponentially within a short period before interventions are sought and effectively implem...